29 C
Vientiane
Tuesday, September 2, 2025
spot_img
Home Blog Page 1419

Harbour BioMed Receives NMPA IND Clearance for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Feb. 5, 2025 /PRNewswire/ — Harbour BioMed (HKEX: 02142, the “Company”), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology and immunology, today announced that the National Medical Products Administration (NMPA) of China has approved the Investigational New Drug (IND) application for HBM9378/SKB378 (also known as WIN378), a fully human antibody targeting thymic stromal lymphopoietin (TSLP), for the treatment of chronic obstructive pulmonary disease (COPD).

COPD is a progressive respiratory condition with major complications, including cardiovascular risk, respiratory failure, and lung cancer. The disease imposes a significant and growing burden both in terms of healthcare costs and societal impact. There is an urgent need for new therapeutic options to alleviate the daily suffering of COPD patients and improve their quality of life.

TSLP plays a critical role in triggering airway inflammation by activating immune responses that contribute to COPD progression. HBM9378/SKB378 is designed to inhibit the TSLP-mediated signaling pathway, aiming to reduce airway inflammation and improve lung function in patients with COPD.

“This regulatory clearance from the NMPA marks an important milestone in advancing our efforts to address significant unmet needs in immunological diseases,” said Dr. Jingsong Wang, Founder, Chairman, and CEO of Harbour BioMed. “HBM9378/SKB378 represents a potential best-in-class, long-acting TSLP antibody with exceptional biophysical properties. We will continue exploring its therapeutic potential to benefit patients worldwide.”

On January 10, 2025, Harbour BioMed and Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun-Biotech”) entered into a global licensing agreement (excluding Greater China and select Southeast and West Asian countries) with Windward Bio for HBM9378/SKB378. Under the terms of the agreement, Harbour BioMed and Kelun-Biotech are eligible to receive $45 million in upfront and near-term milestone payments, including both cash and equity interest in Windward Bio’s parent company. The total potential deal value, including upfront and milestone payments, could reach up to $970 million, in addition to tiered royalties ranging from single to double digits on net sales.

About HBM9378/SKB378

HBM9378/SKB378 (also known as WIN378) is a co-development project jointly conducted by Harbour BioMed and Kelun-Biotech, with both parties equally sharing its rights in Greater China and several Southeast and West Asian countries. It is a fully human monoclonal antibody targeting TSLP, generated from the two heavy chains and two light chains (H2L2) Harbour Mice® platform. It inhibits the TSLP-mediated signaling pathway by blocking the interaction between TSLP and its receptor, which is a well-validated cytokine plays a key role in the development and progression of various immunological conditions, including asthma and chronic obstructive pulmonary disease (COPD). Inhibition of this pathway has shown benefits across multiple inflammatory phenotypes. The antibody’s long half-life optimization and outstanding biophysical properties provide a favorable dosing advantage.

Currently, Harbour BioMed has completed a phase I clinical trial in China under an IND for the treatment of moderate-to-severe asthma. A phase II clinical trial for this indication is set to begin soon.

About Harbour BioMed

Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on immunology and oncology. The Company is building its robust portfolio and differentiated pipeline through internal R&D capability, collaborations with co-discovery and co-development partners, and select acquisitions.

The proprietary antibody technology platform Harbour Mice® generates fully human monoclonal antibodies in two heavy and two light chains (H2L2) format, as well as heavy chain only (HCAb) format. Building upon the HCAb antibodies, the HCAb-based immune cell engagers (HBICE®) bispecific antibody technology is capable of delivering tumor-killing effects unachievable by traditional combination therapies. Integrating Harbour Mice®, and HBICE® with a single B cell cloning platform, our antibody discovery engine is highly unique and efficient for the development of next-generation therapeutic antibodies. For further information, please refer to www.harbourbiomed.com.

Fujitsu to highlight AI-powered network technologies at MWC Barcelona 2025

Use case demonstrations will show how Fujitsu AI and network technologies can contribute to a more sustainable and connected future

KAWASAKI, Japan, Feb. 5, 2025 /PRNewswire/ — Fujitsu Limited today announces its participation in Mobile World Congress Barcelona 2025 (MWC25). Under the theme “Boundless Potential,” Fujitsu will unveil its latest advancements in network technologies and enterprise solutions, and highlight how AI is revolutionizing networks and driving business transformation.

At booth 2G60 (Hall 2), Fujitsu will offer visitors interactive demonstrations of AI-enhanced network infrastructure, including solutions for optimizing 5G and optical networks, showcasing improved resource allocation and reduced latency. Attendees will see innovative AI applications in action, such as AI agents improving efficiency in manufacturing and IT operations and an ocean digital twin utilizing AI and autonomous underwater vehicles (AUVs) for environmental monitoring and predictive maintenance of marine infrastructure. Fujitsu will also highlight the high-performance, energy-efficient processor FUJITSU-MONAKA (1), showcasing its capabilities in accelerating AI workloads and reducing power consumption.

Customer use cases and demonstrations will illustrate how Fujitsu’s solutions are already contributing to sustainability transformation (SX) by optimizing supply chains, enhancing resilience, and driving operational efficiency across various sectors.

For more information, or to arrange an interview or tour of the Fujitsu booth, please contact us below or visit MWC Barcelona 2025 Fujitsu Website.

Overview of MWC Barcelona 2025 and Fujitsu booth

  • Date: Monday, March 3, 2025 to Thursday, March 6, 2025
  • Venue: Fira Gran Via, Barcelona, Spain
  • Fujitsu booth: 2G60 (Hall 2)
[1] FUJITSU-MONAKA :
This is based on results obtained from a project subsidized by the New Energy and Industrial Technology Development Organization (NEDO).

For full release click here
https://www.fujitsu.com/global/about/resources/news/press-releases/2025/0205-01.html

JDSS Elevates Wine Culture in Thailand with Exclusive New Offerings

BANGKOK, Feb. 5, 2025 /PRNewswire/ — JDSS, a premier wine and spirits import and distribution company in Asia, proudly announces its exclusive distribution agreements with several prominent wine brands.

Effective immediately, JDSS will manage all exclusive distribution and marketing activities of specially selected wines from over eight renowned wine brands, which include Ridolfi Montalcino, Mendel Wines, Amelia Park Wines and Casa E. Di Mirafiore, Quinta das Marias, Santos & Seixo Wines, Bodegas Bodem, Luis Felipe Edwards, in select regions in Thailand.

JDSS’s latest lineup includes a diverse selection of wines deeply rooted in tradition. This collection features premium varieties from the esteemed Margaret River region in Western Australia, such as Semillon Sauvignon Blanc, Chardonnay, Shiraz, and Cabernet Merlot. Additionally, it showcases classified growths from Bordeaux’s Left Bank and wines from the Right Bank’s Pomerol and Saint-Émilion. The lineup also highlights varietals from the Loire Valley, one of the world’s most renowned wine-producing areas in central France, among other offerings.

The distribution will enhance the availability of these wines in the provinces of Thailand. JDSS is collaborating with wholesalers to make it more convenient for consumers to access its wines, ensuring efficient after-sales services and fast delivery.

JDSS is dedicated to represent iconic wine brands from world-renowned wine regions while enhancing consumer understanding of traditional and modern winemaking practices and distinguished vineyards and wineries.

“Wines are beginning to capture the attention of affluent consumers in Thailand, where drinking is commonplace. There already are clear signals of the incredible potential for wines to be seen as a highly cherished possession and to be shared exclusively with family and friends on special occasions in this country,” said James Ong, founder of JDSS. “We understand the wine market in Thailand, and the exclusive distribution agreements reflect our dedication and excitement in bringing the best wines worldwide and nurturing a lively, sophisticated wine culture right here.”

A key factor in the success of JDSS is its leadership team, led by seasoned entrepreneur James Ong. With over 30 years of experience in the wines, spirits, and alcohol industry, Ong boasts an impressive track record of providing exceptional service and high-quality wines to clients. Previously, he has managed wine sales teams and shared his extensive wine knowledge with enthusiasts across Asia. Understanding the evolving taste preferences of consumers and the demand for wine in the region, he founded JDSS in 2024 and currently oversees its day-to-day operations.

Also part of the team is Thanit Apipatana, a Bangkok-based entrepreneur and strategic advisor who provides counsel on the business sales and go-to-market strategies in Thailand.

“When we evaluated Thailand to determine its viability as a market, we noticed that people possessed different stages of understanding about these wines but were eager to learn more. Interestingly, we also identified a market segment deeply attuned to the aromatic complexities of different wine classifications,” said Apipatana. “In this dazzlingly diverse market, we feel privileged to showcase some of the best wines in the world and elevate them to the status they deserve in Thailand.”

Customers can contact JDSS to explore its extensive selection of wines specially catered for F&B professionals, corporate events, wedding banquets, private tasting sessions and celebrating their special occasions.

About JDSS

JDSS is an importer and marketer of the world’s finest wines, spirits, sakes and whiskeys based in Thailand. Led by seasoned wine veteran James Ong, JDSS is constantly refining the drinking experience and expanding its wine offerings and services to stay ahead of changing consumer preferences. For enquiries about JDSS, please send it via the JDSS Line application at https://line.me/ti/p/J2FYSuH1u2.

AgiBot Establishes Robotics and AI Solutions Enterprise in Kazakhstan

SHANGHAI, Feb. 5, 2025 /PRNewswire/ — AgiBot, a Leader in AI and Robotics Integration, is to establish a Robotics and AI Solutions Enterprise in Kazakhstan.

A memorandum of understanding was signed between the Minister of Digital Development and Aerospace Industry, Zhaslan Madiev, and the leadership of AgiBot, ewpartners, and Qazaqstan Investment Corporation at the annual Digital Almaty 2025 forum. As part of this partnership, AgiBot plans to establish a joint venture in Kazakhstan for the production and implementation of robotics and AI solutions.


Founded in February 2023, AgiBot specializes in the development and production of general-purpose humanoid robots. The company is actively advancing AI and robotics technologies, creating robots for a wide range of applications—from industrial to household tasks. As of December 2024, the number of robots produced at AgiBot’s Shanghai facility had reached 1,000 units.

Notably, Kazakhstan has been chosen as the first country in the region for localizing production and further exporting these technologies. As part of the partnership, AgiBot, together with the Ministry of Digital Development and Aerospace Industry, plans to launch a “data factory” for training robots and robotic systems.

“A partnership with such an advanced company as AgiBot marks an important milestone in the development of the robotics industry. It is particularly significant that our collaboration includes the localization of robot production in Kazakhstan. This will not only allow us to launch an enterprise in one of the most promising sectors of mechanical engineering but also to enhance our expertise and create a national center of excellence in robotics,” emphasized Zhaslan Madiev, Minister of Digital Development and Aerospace Industry.

The joint initiative is considered to be financed with the participation of private equity fund ewpartners and Qazaqstan Investment Corporation.

In the near future, a joint R&D center and an exhibition of AgiBot’s prototype robots are expected to be set up at the Alem AI International Center for Artificial Intelligence. Additionally, the company plans to collaborate with Kazakhstani universities to launch joint research projects and train students in robot assembly.

MEDCOENERGI IMPROVES MSCI ESG RATING TO “AA”

JAKARTA, Indonesia, Feb. 5, 2025 /PRNewswire/ — PT Medco Energi Internasional Tbk (MedcoEnergi) has received an upgrade to its MSCI ESG rating, from “A” to “AA”. This recognition positions MedcoEnergi as a leader in sustainability within the exploration and oil and gas industry.

Oyong Platform, East Java Asset
Oyong Platform, East Java Asset

The MSCI ESG rating assesses companies based on their ability to manage ESG risks compared to industry peers. Companies are ranked as leaders (AAA, AA), average (A, BBB, BB), or laggards (B, CCC). Operating in a high-risk sector, MedcoEnergi has demonstrated strong ESG management, exceeding industry standards.

The company’s latest rating upgrade is its third upgrade in five years, reflecting consistent enhancements in ESG performance. MedcoEnergi has strengthened its community development programs in the last five years and issued standalone Human Rights Policy in 2024. The company is also advancing its emission reduction initiatives in line with its Net Zero commitments for Scope 1 and 2 by 2050, and Scope 3 by 2060. Additionally, MedcoEnergi has maintained a Total Recordable Injury Rate well below the International Association of Oil & Gas Producers (IOGP) overall and Asia/Australasia regional averages.

“This upgrade to ‘AA from MSCI acknowledges our sustainability efforts and reinforces our commitment to integrating ESG into all aspects of our operations,” said Hilmi Panigoro, President Director of MedcoEnergi.

IMAX Soars to Highest Grossing Chinese New Year Ever with $53 Million

IMAX Box Office in China’s Peak Moviegoing Period up +57% over Previous Best; Animated Blockbuster “Ne Zha 2” Leads the Way with $36 Million and Counting


NEW YORK, US and SHANGHAI, CHINA – Media OutReach Newswire – 5 February 2025 – IMAX Corporation (NYSE: IMAX) shattered its box office record for Chinese New Year, delivering $53 million during the 7-day holiday period concluded February 4. The busiest window annually for moviegoing in China, the 2025 Chinese New Year holiday saw IMAX exceed its previous record of $34 million set in 2023 by a whopping +57%. IMAX also delivered its highest attendance ever for the Chinese New Year, with 5.5 million admissions nationwide.

While the holiday has concluded, IMAX’s record-breaking slate of Chinese New Year films will continue to play throughout the IMAX China network for another month. IMAX delivered its highest market share of the holiday – 4.3% on only 1% of screens – and $7.3 million on the final day of the period, demonstrating the continued strength of the slate.

“Chinese New Year unleashed one of the most impressive surges in moviegoing we’ve seen in recent years, anywhere in the world — leaving a slew of broken IMAX records in its wake,” said Rich Gelfond, CEO of IMAX. “This is a shot of adrenaline for moviegoing in China that comes at just the right time, with a tentpole heavy slate of local language and Hollywood films ahead for 2025.”

Enlight’s “Ne Zha 2” — the highly anticipated sequel to the 2019 smash hit — led the way with $36 million. The film scored the biggest opening weekend in IMAX history for an animated film with $22 million and is already the fourth highest grossing IMAX local language release of all time. “Ne Zha 2” took just seven days to top its predecessor “Ne Zha,” which earned $35 million in China over its two-month IMAX run.

Alibaba’s fantasy “Creation of the Gods II: Demon Force” delivered $7.6 million and Bona’s naval drama “Operation Hadal” added another $2.7 million in IMAX. Both films featured IMAX-exclusive expanded aspect ratio. China Film Group’s martial arts actioner “Legend of the Condor Heroes: The Gallants” scored $3.7 million while Maoyan’s “Detective Chinatown 1900” contributed an additional $2.7 million in IMAX.

“The message from audiences is clear: IMAX is their first choice,” said Daniel Manwaring, CEO of IMAX China. “Riding on a stronger-than-ever audience preference, IMAX has transformed moviegoing into a cultural phenomenon and a social talking point. We deeply value their brand loyalty and are confident that we can carry this momentum throughout what is poised to be one of the strongest years for Chinese local language films.”

With the 2025 Chinese New Year slate, IMAX continues to expand its strategy of bringing local language films to audiences around the world. “Creation of The Gods II: Demon Force” and “Detective Chinatown 1900” were also released in select IMAX locations across 11 countries worldwide, bringing in more than $1.2 million outside of China. “Ne Zha 2” will be shown exclusively in IMAX theaters in Australia and New Zealand beginning February 6th.

The Chinese New Year slate will continue to play in China for the next month, alongside Disney’s “Captain America: Brave New World” and the re-release of the classic romance “In Mood for Love”.
Hashtag: #IMAX

The issuer is solely responsible for the content of this announcement.

About IMAX China

IMAX China is a subsidiary of IMAX Corporation and was incorporated as a limited liability company under the laws of Cayman Islands. IMAX China was established by IMAX Corporation specifically to oversee the expansion of IMAX’s business throughout Greater China. Shares of IMAX China trade on the Hong Kong Stock Exchange under the stock code “1970.”

About IMAX Corporation  

IMAX, an innovator in entertainment technology, combines proprietary software, architecture, and equipment to create experiences that take you beyond the edge of your seat to a world you’ve never imagined. Top filmmakers and studios are utilizing IMAX systems to connect with audiences in extraordinary ways, making IMAX’s network among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto, and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of September 30, 2024, there were 1,788 IMAX systems (1,714 commercial multiplexes, 12 commercial destinations, 62 institutional) operating in 89 countries and territories. Shares of IMAX China Holding, Inc., a subsidiary of IMAX Corporation, trade on the Hong Kong Stock Exchange under the stock code “1970”.

IMAX®, IMAX® 3D, Experience It In IMAX®, The IMAX Experience®, DMR®, Filmed For IMAX®, IMAX LIVE™, and IMAX Enhanced® are trademarks and trade names of IMAX Corporation or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. For more information, visit . You may also connect with IMAX on Instagram (), Facebook (), LinkedIn (), X (), and YouTube ().

Latest service in Hong Kong from Japan. Easy, Healthy Company canteen「My Office Café」

HONG KONG, Feb. 5, 2025 /PRNewswire/ — In Japan, over 2,000 companies have introduced it  in the four years since its release. A popular service in Japan is now available in Hong Kong.

 Click here for more Info!:https://my-officecafe.hk/eng/

New service now available from Japan. Easy, Healthy Company canteen「My Office Café」
New service now available from Japan. Easy, Healthy Company canteen「My Office Café」

Meals at the office>

At lunchtime, many restaurants are so crowded with people coming out of office buildings that it’s hard to get in right away. Even on rainy days or very hot days, it can be a hassle to leave the office to eat. It is also difficult to bring a lunch box every day.

My Office Cafe, a simple and healthy company meal service, is a special service that can quickly solve the stress of eating at the office.

My Office Cafe is a special service that can quickly solve such problems.

Service overview>

“My Office Cafe” allows companies to support their workers and create a better working environment. My Office Cafe” is a service in which a subscribing company pays a service usage fee (from HK$2,300 per month) to allow its employees to enjoy inexpensive (HK$10 or HK$20) and tasty food easily and quickly at a low price. We lend a freezer and microwave oven, and keep a certain number of packs of our products available in the freezer every month. Employees can eat them whenever they like by purchasing the products of their choice from the freezer and heating them up themselves.
* Employees can choose to pay by cash or Payme or credit card. 

About the operating company and food provided>

The operating company SUGARLADY HONG KONG LIMITED expanded into Hong Kong in 2016 as the overseas base of the SL Creations Group. In 2023, we launched Hong Kong’s first welfare service, “My Office Café.” Since our company (our group) was founded in 1970, we have been providing our customers with products that are among the top in Japan in terms of safety and taste, without using synthetic chemical additives (umami seasonings, preservatives, coloring agents, etc.). SUGARLADY HONG KONG imports these carefully selected original products from Japan and provides them to everyone in the office.

Click here for a lineup of approximately 70 types of service products
https://my-officecafe.hk/wp-content/themes/o_p_frozen/src/images/common/menubook_eng.pdf

< Special offer>

・【Special offer 1】: Free tasting sample
・【Special offer 2】: 1 month trial (free service charge)
・【Special offer 3】: Service fee is half price for 2 months

For service inquiries, tasting samples, and trial applications>

SUGARLADY HONG KONGLIMITED/Ms. Blinky Cheung

FLAT A ON 1st FLOOR, CLEVELAND MANSION, NO.5&7 CLEVELAND STREET, CAUSEWAY BAY, HONG KONG

Business hour 10:00-18:00/Regular holiday : Monday, Sunday, Public Holidays

TEL:2562-2560  Whatsapp:+852 6825 5064

1964 Ferrari 250 LM Wins Prestigious The Peninsula Classics Best of The Best Award

PARIS, Feb. 5, 2025 /PRNewswire/ — A stunning 1964 Ferrari 250 LM has been named winner of the 10th annual The Peninsula Classics Best of the Best Award 2024. Presented during an awards ceremony at The Peninsula Paris, the distinction recognises the pinnacle of classic automotive design and engineering. The Ferrari, chosen from a select group of nine vehicles that won awards at the past year’s major concours events, became eligible for consideration after winning the Best in Show honour at the Cavallino Classic in January 2024.

1964 Ferrari 250 LM Wins The Peninsula Classics Best of The Best Award 2024
1964 Ferrari 250 LM Wins The Peninsula Classics Best of The Best Award 2024

“I am truly humbled to receive this distinguished award,” said Mr. Chris Cox, owner of the 1964 Ferrari 250 LM. “It brings me tremendous joy to show a vehicle with such a rich history at the world’s biggest concours, and being selected for The Peninsula Classics Best of the Best Award is the highest honour a car collector can achieve.”

Originally unveiled in Paris in November 1963, the Ferrari 250 LM (for “Le Mans”) is a Grand Touring version of the mid-engined Ferrari 250 P. Featuring a body designed by Pininfarina and built by Scaglietti, it was intended to replace the 250 GTO, one of Ferrari’s most successful race cars. Although Ferrari was unable to obtain LM approval in the GT class, the model achieved significant success when a 250 LM won the 1965 Le Mans 24 Hours and the 1965 International Trophy for GT Prototypes. One of only 32 produced, this particular 250 LM enjoyed an accomplished racing career from 1965 to 1967, with notable victories at Brands Hatch, Snetterton, and Silverstone in 1966. The car later participated in two of motorsport’s most iconic endurance races – the 24 Hours of Daytona in 1966 and the 24 Hours of Le Mans in 1968.

Acquired by its current owner in 2018, the 1964 Ferrari 250 LM is a celebrated piece of Ferrari history. It was showcased at the Enzo Ferrari Museum in Modena, Italy, as part of the “Ferrari Forever” 75th anniversary exhibition in 2022; it has also been displayed at major concours, including the 2022 Pebble Beach Concours d’Elegance – and most recently, at Casa Ferrari at Pebble Beach in 2024 to celebrate Ferrari’s 70th anniversary in the United States. 

“The winning 1964 Ferrari 250 LM is much more than just a stunning vehicle,” said Christian Philippsen, co-founder of The Peninsula Classics Best of the Best Award. “This is one of Ferrari’s most revolutionary models, with a rich competitive history and incredible provenance. We are thrilled to honour a motorsport legend of this calibre as this year’s Best of the Best.”

Also competing for the award were eight other exquisite classic cars: a 1932 Alfa Romeo 8C 2300 Spider, a 1957 Ferrari 335 S, a 1937/1946 Delahaye 145 Cabriolet, a 1947 Delahaye 135MS Narval Cabriolet, a 1934 Bugatti Type 59 Sports, a 1937 Bugatti Type 57S Roadster, a 1928 Bugatti Type 35C Grand Prix, and a 1937 Rolls-Royce Phantom III Convertible.

The judges for The Peninsula Classics Best of the Best Award 2024 comprised a distinguished selection of automotive designers, enthusiasts, and executives – including renowned designers Peter Brock and Fabio Filippini, former General Motors Vice President of Design Ed Welburn, and Henry Ford III. Notable royalty and celebrity motorsport collectors also took part in judging, including HRH Prince Michael of Kent, HH Rana Manvendra Singh of Barwani, Peter Marino, Ralph Lauren, and Jay Leno.

Launched by the Hon. Sir Michael Kadoorie in 2015, The Peninsula Classics Best of the Best Award is dedicated to the appreciation, preservation and restoration of fine motorcars. Sponsored by The Peninsula Hotels, a global luxury hospitality company with a 158-year history, the awards ceremony brings together the concours circuits’ elite Best of Show winners from around the globe, enabling modern-day enthusiasts to see, learn about and cherish these magnificent examples of automotive history.

# # #

About The Peninsula Classics Best of the Best Award

Through a shared desire to celebrate the best of what defines the automotive world, The Hon. Sir Michael Kadoorie, chairman of The Hongkong and Shanghai Hotels, Limited, launched The Peninsula Classics Best of the Best Award in 2015 with co-founders William E. (Chip) Connor, Bruce Meyer and Christian Philippsen. Each founder shares a common passion and appreciation of fine motorcars, the preservation of their heritage, and immaculate restoration projects. The award, sponsored by The Peninsula Hotels, brings together the concours circuits’ elite Best of Show winners from around the globe, enabling modern-day enthusiasts to encounter, learn about and cherish these magnificent examples of automotive history.

Michelle Yeoh Celebrates The Peninsula Classics Best of the Best Award
Michelle Yeoh Celebrates The Peninsula Classics Best of the Best Award

1964 Ferrari 250 LM
1964 Ferrari 250 LM

The Peninsula Classics Best of the Best Award in The Peninsula Paris
The Peninsula Classics Best of the Best Award in The Peninsula Paris

The 1964 Ferrari 250 LM at The Peninsula Paris
The 1964 Ferrari 250 LM at The Peninsula Paris